202
Participants
Start Date
April 30, 2014
Primary Completion Date
August 31, 2015
Study Completion Date
August 31, 2015
Placebo Gel
6 mL of Placebo Gel administered TID for 6 weeks
OLT1177 Gel
6 mL of OLT1177 Gel (5%) administered TID for 6 weeks
Charlottesville Medical Research Center, LLC, Charlottesville
Clinical Trials of South Carolina, Charleston
Coastal Carolina Research Center, Inc, Mt. Pleasant
Avail Clinical Research, DeLand
International Clinical Research - US, LLC, Sanford
Miami Research Associates, LLC, South Miami
Sunrise Medical Research, Inc., Lauderdale Lakes
Health Awareness, Inc., Jupiter
Achieve Clinical Research, LLC, Birmingham
Healthcare Research Network, Inc., Hazelwood
Best Clinical Trial, LLC, New Orleans
Clinical Research Consulting, LLC, Milford
Omega Medical Research, Warwick
Lead Sponsor
Olatec Therapeutics LLC
INDUSTRY